Article Text

Download PDFPDF

77 Contemporary prognosis of patients hospitalised with a primary diagnosis of heart failure: the national heart failure audit of england & wales
  1. John Cleland1,
  2. Aminat Shote2,
  3. Suzanna Hardman3,
  4. Theresa McDonagh4
  1. 1Robertson Centre for Biostatistics & Clinical Trials
  2. 2St Bartholomews and Queen Mary University, NICOR, London.
  3. 3Whittington Hospital, Cardiology, London.
  4. 4Kings College London, Cardiology, London.


Background The National Heart Failure Audit for England & Wales collects information on hospital deaths and discharges attributed primarily to heart failure. The data collection tool is web-based with >250 fields. Mandatory data include age, sex, deprivation-index, admission symptoms, aetiology and co-morbidity, electro- and echo-cardiographic data, standard laboratory tests and discharge medications. Patients are followed up for re-admissions and deaths through linkage to national records.

Purpose To describe the contemporary in-patient and post-discharge mortality of patients with a primary death or discharge diagnosis of heart failure reported by hospitals in England & Wales, stratified by age, sex and left ventricular phenotype.

Methods Descriptive. Patient characteristics are described as medians with inter-quartile ranges. Time to event analyses using Kaplan-Meier.

Results Altogether, 157,682 unique patients (>75% of all relevant admissions) were entered into the registry between April 2014-March 2018, of whom 45% were women (median age of 82 (75–88) years; 56% with LVEF <40%) and 55% were men (median age of 78 (69–85) years; 74% with LVEF <40%. Amongst 45,772 patients surviving to discharge in 2017–18 with an LVEF <40%, 92% were discharged on a loop diuretic, 22% on digoxin, 72% on an ACE inhibitor, 23% on an ARB, 83% on an ACE inhibitor and/or ARB, 89% on a beta-blocker and 56% on an MRA. Patients who received disease-modifying agents were younger and had a better prognosis.

Age, but neither sex nor LVEF, was a strong determinant of both in-patient and post-discharge mortality. In-patient mortality ranged from 3.2% in those aged <45 years to 16.5% in those aged >85 years. One-year mortality for patients who survived to discharge ranged from 10.4% in those aged <45 years to 45.6% in those aged >85 years (figure shows age-stratified, post-discharge, one-year mortality for people enrolled 2014–17).

Conclusion More than 60% of people hospitalised primarily for heart failure in England & Wales are aged >75 years and most have a reduced left ventricular ejection fraction. Treatment and outcome are strongly influenced by age. In-patient and post-discharge mortality remain high for older patients hospitalised with a primary diagnosis of heart failure.

Conflict of Interest None

  • Heart Failure
  • Audit
  • Mortality

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.